ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer

September 17, 1977

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014